MyMD Pharmaceuticals Inc (NASDAQ: MYMD) Launching Substitute To JAK Inhibitors
MyMD Pharmaceuticals Inc (NASDAQ: MYMD) is focused on developing a couple of therapeutic platforms to provide a healthy lifespan to the patient. The company recently announced the data conducted by Eurofins Discovery indicating similar results between FDA-approved JAK inhibitor drugs and the company clinical compound MYMD-1 to treat autoimmune and inflammatory diseases. MYMD-1 can substitute JAK inhibitor: As per the company, data released by Eurofins Discovery based on the study…